Literature DB >> 26821615

A log-rank-type test to compare net survival distributions.

Nathalie Grafféo1,2, Fabienne Castell3, Aurélien Belot4,5,6,7,8, Roch Giorgi9,10,11.   

Abstract

In population-based cancer studies, it is often interesting to compare cancer survival between different populations. However, in such studies, the exact causes of death are often unavailable or unreliable. Net survival methods were developed to overcome this difficulty. Net survival is the survival that would be observed if the disease under study was the only possible cause of death. The Pohar-Perme estimator (PPE) is a nonparametric consistent estimator of net survival. In this article, we present a log-rank-type test for comparing net survival functions (as estimated by PPE) between several groups. We put the test within the counting process framework to introduce the inverse probability weighting procedure as required by the PPE. We built a stratified version to control for categorical covariates that affect the outcome. We performed simulation studies to evaluate the performance of this test and worked an application on real data.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Cancer; Log-rank; Net survival; Pohar-Perme estimator; Stochastic process; Test

Mesh:

Year:  2016        PMID: 26821615     DOI: 10.1111/biom.12477

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  7 in total

1.  On comparison of net survival curves.

Authors:  Klemen Pavlič; Maja Pohar Perme
Journal:  BMC Med Res Methodol       Date:  2017-05-02       Impact factor: 4.615

2.  To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.

Authors:  Zoéwendtalé Cyrille Compaoré; Elisabeth Monnet; Aurélie Gérazime; Florence Molinié; Anne-Valérie Guizard; Patricia Delafosse; Tienhan Sandrine Dabakuyo-Yonli; Gaëlle Coureau; Karima Hammas; Sandrine Plouvier; Simona Bara; Gautier Défossez; Bénédicte Lapôtre-Ledoux; Laetitia Daubisse-Marliac; Tania d'Almeida; Guy Launoy; Laura Mansi; Brigitte Trétarre; Anne-Sophie Woronoff
Journal:  Cancer Causes Control       Date:  2022-01-26       Impact factor: 2.506

3.  Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.

Authors:  Alix Augustin; Steven Le Gouill; Rémy Gressin; Aurélie Bertaut; Alain Monnereau; Anne-Sophie Woronoff; Brigitte Trétarre; Patricia Delafosse; Xavier Troussard; Anne Moreau; Olivier Hermine; Marc Maynadié
Journal:  J Cancer Res Clin Oncol       Date:  2017-10-11       Impact factor: 4.553

4.  Correcting for misclassification and selection effects in estimating net survival in clinical trials.

Authors:  Juste Aristide Goungounga; Célia Touraine; Nathalie Grafféo; Roch Giorgi
Journal:  BMC Med Res Methodol       Date:  2019-05-16       Impact factor: 4.615

5.  Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia.

Authors:  Charles Tacquard; Alexandre Mansour; Alexandre Godon; Julien Godet; Julien Poissy; Delphine Garrigue; Eric Kipnis; Sophie Rym Hamada; Paul Michel Mertes; Annick Steib; Mathilde Ulliel-Roche; Bélaïd Bouhemad; Maxime Nguyen; Florian Reizine; Isabelle Gouin-Thibault; Marie Charlotte Besse; Nived Collercandy; Stefan Mankikian; Jerrold H Levy; Yves Gruel; Pierre Albaladejo; Sophie Susen; Anne Godier
Journal:  Chest       Date:  2021-01-16       Impact factor: 9.410

6.  Does access to care play a role in liver cancer survival? The ten-year (2006-2015) experience from a population-based cancer registry in Southern Italy.

Authors:  Walter Mazzucco; Francesco Vitale; Sergio Mazzola; Rosalba Amodio; Maurizio Zarcone; Davide Alba; Claudia Marotta; Rosanna Cusimano; Claudia Allemani
Journal:  BMC Cancer       Date:  2021-03-24       Impact factor: 4.430

7.  Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study.

Authors:  Seung-Hyuk Shim; Myong Cheol Lim; Dahhay Lee; Young-Joo Won; Hyeong In Ha; Ha Kyun Chang; Hyunsoon Cho
Journal:  J Gynecol Oncol       Date:  2021-10-13       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.